Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Seaforth ...

But in our case lets say our company is worth $100M and has 100M OS and the other company is worth $100M and brings no stock to the table. I can see them splitting the shares PTSC has purchased between them but I don't understand why the shares OS wouldn't stay the same but value is doubled? Both companies get the benefit of 100% ownership together in the MMP. Forgive my ignorance on this subject.

All the best,

Steve

Share
New Message
Please login to post a reply